National Hospital Organization Kyushu Medical Center

Fukuoka, Fukuoka 810-8563

0 studies enrolling now · 2 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Follicular Lymphoma, High-risk Transient Ischemic Attack, Prevention of Ischemic Stroke

Studies at this site

• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed